Monoclonal Gammopathy of Uncertain Significance
2 clinical trials · Condition
◉ Watch Monoclonal Gammopathy of Uncertain Significance
| Record | Firm | Date |
|---|---|---|
| Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers (NCT06987708) | Hackensack Meridian Health | 2026-07-01 |
| Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy (NCT05939037) | UMC Utrecht | 2024-03-01 |
Track Monoclonal Gammopathy of Uncertain Significance automatically
Every clearance here is in the API, with alerts when new ones post.